James Liu - Mar 26, 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
VP ACCT, Cntlr, Treasurer, PAO
Signature
/s/ James Liu
Stock symbol
OCX
Transactions as of
Mar 26, 2025
Transactions value $
$0
Form type
4
Date filed
3/28/2025, 04:05 PM
Previous filing
May 22, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Award $0 +10K $0.00 10K Mar 26, 2025 Common Stock 10K $3.18 Direct F1
transaction OCX Restricted Stock Units Award $0 +18.9K $0.00 18.9K Mar 26, 2025 Common Stock 18.9K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
F2 33 and 1/3% of the restricted stock units will vest on each of the one-, two- and three-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.